TWD 23.9
(-1.65%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 777.76 Million TWD | 6.41% |
2022 | 452.9 Million TWD | 15.25% |
2021 | 392.95 Million TWD | 16.04% |
2020 | 338.65 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 488.72 Million TWD | 291.96% |
2024 Q2 | 145.97 Million TWD | -70.13% |
2023 Q3 | 124.68 Million TWD | -2.11% |
2023 FY | 481.94 Million TWD | 6.41% |
2023 Q4 | 124.68 Million TWD | 0.0% |
2023 Q2 | 127.37 Million TWD | 0.0% |
2023 Q1 | 127.37 Million TWD | 9.33% |
2022 FY | 452.9 Million TWD | 15.25% |
2022 Q4 | 116.51 Million TWD | 0.0% |
2021 FY | 392.95 Million TWD | 16.04% |
2020 FY | 338.65 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Lytone Enterprise, Inc. | 169.49 Million TWD | -358.883% |
Vetnostrum Animal Health Co., Ltd. | 245.32 Million TWD | -217.034% |